Position in STE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$371,024
+$43,089 QoQ
Shares Held
1,762
+18.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#510
of 822 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in STE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $28,436,684 across 20 Medical Devices names. STE ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
100,143 | $9,086,975 | |
| 2 | SYK |
Stryker Corp
|
10,956 | $3,449,387 | |
| 3 | MDT |
Medtronic plc
|
42,398 | $3,316,795 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
27,913 | $1,786,711 | |
| 5 | BSX |
Boston Scientific Corp
|
38,473 | $1,642,027 | |
| 6 | EW |
Edwards Lifesciences Corp
|
17,698 | $1,600,961 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
16,879 | $1,453,113 | |
| 8 | GMED |
Globus Medical Inc
|
9,886 | $781,092 |
All Filings in STE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $371,024 | 1,762 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $327,935 | 1,483 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $573,715 | 2,263 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $661,407 | 2,673 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $809,301 | 3,369 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,460,759 | 6,445 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,369,235 | 6,661 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,772,239 | 7,307 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,505,166 | 6,856 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $329,361 | 1,465 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $320,321 | 1,457 | Shares | Sole | 2024-02-05 | |
| No filing history on record for this holder in this stock. | ||||||